ANAVEX3-71-002 trial achieved its primary endpoint demonstrating safety and tolerability in both male and female adults Oral ANAVEX®3-71 tablet exhibits superior pharmacokinetics compared to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback